N

NuCana plc
D

NCNA

1.26000
USD
0.02
(1.61%)
مغلق
حجم التداول
2,284
الربح لكل سهم
-14
العائد الربحي
-
P/E
-0
حجم السوق
2,830,464
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    AQST
    -0.13000
    (-2.84%)
    4.44500 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    C
    CODX
    -0.04000
    (-3.64%)
    1.06000 USD
    E
    EBS
    -1.55000
    (-16.74%)
    7.71000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    T
    TBIO
    0
    (0%)
    0.000000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    المزيد
الأخبار

العنوان: NuCana plc

القطاع: Healthcare
الصناعة: Biotechnology
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.